DexCom, Inc. (DXCM) Analysts See $0.03 EPS; Amber Road (AMBR)’s Sentiment Is 1.6

February 20, 2018 - By Richard Conner

Analysts expect DexCom, Inc. (NASDAQ:DXCM) to report $0.03 EPS on February, 27.They anticipate $0.12 EPS change or 133.33% from last quarter’s $-0.09 EPS. DXCM’s profit would be $2.61 million giving it 477.83 P/E if the $0.03 EPS is correct. After having $-0.03 EPS previously, DexCom, Inc.’s analysts see -200.00% EPS growth. The stock increased 1.11% or $0.63 during the last trading session, reaching $57.34. About 639,336 shares traded. DexCom, Inc. (NASDAQ:DXCM) has risen 9.41% since February 20, 2017 and is uptrending. It has underperformed by 7.29% the S&P500.

Amber Road, Inc. provides cloud-based global trade management solutions in the United States and internationally. The company has market cap of $264.16 million. The companyÂ’s GTM solutions include modules for logistics contract and rate management; supply chain visibility and event management; international trade compliance; and global knowledge trade content database, supply chain collaboration with overseas factories and vendors, and duty management solutions to importers and exporters, nonvessel owning common carriers (resellers), and ocean carriers. It currently has negative earnings. It provides its solution to various industries, including chemical/pharmaceutical, high technology/electronics, industrial/manufacturing, logistics, gas and oil, and retail/apparel through a software-as-a-service model.

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. The company has market cap of $4.98 billion. The firm offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. It currently has negative earnings. The Company’s products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patient's mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management.

Among 23 analysts covering Dexcom (NASDAQ:DXCM), 16 have Buy rating, 1 Sell and 6 Hold. Therefore 70% are positive. Dexcom had 63 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by BTIG Research on Monday, October 31. Raymond James downgraded DexCom, Inc. (NASDAQ:DXCM) on Thursday, September 28 to “Market Perform” rating. On Thursday, November 2 the stock rating was maintained by Canaccord Genuity with “Buy”. The rating was downgraded by Northland Capital on Thursday, January 4 to “Underperform”. The rating was maintained by BMO Capital Markets on Wednesday, January 17 with “Buy”. The firm has “Outperform” rating by Oppenheimer given on Monday, December 19. Canaccord Genuity maintained the stock with “Buy” rating in Wednesday, November 2 report. The stock of DexCom, Inc. (NASDAQ:DXCM) has “Equal-Weight” rating given on Thursday, November 2 by Barclays Capital. The rating was downgraded by JP Morgan on Thursday, September 28 to “Neutral”. The stock has “Outperform” rating by Cowen & Co on Thursday, September 28.

Since August 23, 2017, it had 0 buys, and 9 selling transactions for $2.15 million activity. Pacelli Steven Robert sold 1,450 shares worth $101,219. DOUBLEDAY RICHARD also sold $123,053 worth of DexCom, Inc. (NASDAQ:DXCM) shares. On Tuesday, December 12 SAYER KEVIN R sold $353,092 worth of DexCom, Inc. (NASDAQ:DXCM) or 6,000 shares. Another trade for 3,244 shares valued at $234,441 was sold by Balo Andrew K. GREGG TERRANCE H also sold $568,588 worth of DexCom, Inc. (NASDAQ:DXCM) shares.

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.39, from 1.36 in 2017Q2. It is negative, as 59 investors sold DexCom, Inc. shares while 69 reduced holdings. 31 funds opened positions while 93 raised stakes. 98.30 million shares or 1.76% more from 96.59 million shares in 2017Q2 were reported. Eqis Cap Mgmt holds 0.04% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 13,749 shares. Ray Gerald L & reported 11,275 shares stake. Moreover, Marble Harbor Investment Counsel Ltd has 0.38% invested in DexCom, Inc. (NASDAQ:DXCM) for 37,940 shares. Gemmer Asset Mgmt Limited has invested 0% in DexCom, Inc. (NASDAQ:DXCM). Price T Rowe Inc Md has invested 0.04% in DexCom, Inc. (NASDAQ:DXCM). Commonwealth Equity Svcs holds 4,082 shares. Winslow Cap Mngmt holds 0% in DexCom, Inc. (NASDAQ:DXCM) or 811 shares. Ellington Management Group Ltd Llc has invested 0.1% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Pub Employees Retirement Of Ohio invested 0.01% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Moreover, Valley Natl Advisers has 0.01% invested in DexCom, Inc. (NASDAQ:DXCM) for 495 shares. Gamco Invsts Et Al invested 0.01% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Td Asset Management Inc, Ontario – Canada-based fund reported 36,254 shares. Envestnet Asset Mngmt Inc reported 15,593 shares. Old Natl Comml Bank In has invested 0.03% in DexCom, Inc. (NASDAQ:DXCM). Weatherly Asset Management L P reported 0.12% stake.

Gagnon Advisors Llc holds 3.84% of its portfolio in Amber Road, Inc. for 659,645 shares. Gagnon Securities Llc owns 1.30 million shares or 3.59% of their US portfolio. Moreover, Whetstone Capital Advisors Llc has 2.38% invested in the company for 680,415 shares. The United Kingdom-based Herald Investment Management Ltd has invested 2.26% in the stock. Needham Investment Management Llc, a New York-based fund reported 1.06 million shares.

The stock decreased 0.62% or $0.06 during the last trading session, reaching $9.68. About 858,579 shares traded or 399.26% up from the average. Amber Road, Inc. (AMBR) has risen 46.06% since February 20, 2017 and is uptrending. It has outperformed by 29.36% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 4 sales for $597,425 activity.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>